Last reviewed · How we verify
Metoprolol- Toprol XL — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Metoprolol- Toprol XL (Metoprolol- Toprol XL) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metoprolol- Toprol XL TARGET | Metoprolol- Toprol XL | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metoprolol- Toprol XL CI watch — RSS
- Metoprolol- Toprol XL CI watch — Atom
- Metoprolol- Toprol XL CI watch — JSON
- Metoprolol- Toprol XL alone — RSS
Cite this brief
Drug Landscape (2026). Metoprolol- Toprol XL — Competitive Intelligence Brief. https://druglandscape.com/ci/metoprolol-toprol-xl. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab